Nausheen Khuddus, MD Melissa Elder, MD, PhD
|
|
- Ralph Jefferson
- 6 years ago
- Views:
Transcription
1 Nausheen Khuddus, MD Melissa Elder, MD, PhD
2 Nausheen Khuddus, MD Pediatric Ophthalmologist and Strabismus Specialist Accent Physicians Gainesville, Florida
3 What Is Uveitis? Uveitis is caused by inflammatory responses inside the eye. Inflammation is the body s natural response to tissue damage, germs, or toxins. It produces swelling, redness, and destroys tissues as certain white blood cells rush to the affected part of the body to contain or eliminate the insult.
4 Anatomy: What is Uveitis? The uvea is the middle layer of the eye and contains much of the eye s blood vessels. The uvea consists of the iris, ciliary body, and choroid: Iris: It defines eye color, secretes nutrients to keep the lens healthy. Ciliary Body: located between the iris and the choroid. It helps the eye focus by controlling the shape of the lens, and provides nutrients to the lens. Choroid: A thin, spongy network of blood vessels, which provides nutrients to the retina.
5 Uveitis may be caused by: An attack from the body s own immune system (autoimmunity). Infections or tumors occurring within the eye or in other parts of the body. Trauma to the eye.
6 Uveitis Can last for a short (acute) or a long (chronic) time. Uveitis is specifically described as: Anterior uveitis Intermediate uveitis Posterior uveitis Panuveitis
7 What is Anterior Uveitis? Anterior uveitis occurs in the front of the eye. It is the most common form of uveitis. Many cases occur in healthy people and may only affect one eye, but some are associated with juvenile idiopathic arthritis, skin, gastrointestinal, lung and infectious diseases
8 What is Intermediate Uveitis? Intermediate uveitis is commonly seen in young adults. The center of the inflammation often appears in the vitreous. It has been linked to autoimmune disorders including sarcoidosis and multiple sclerosis.
9 What is Posterior Uveitis? Posterior uveitis is the least common form of uveitis. It primarily occurs in the back of the eye, often involving both the retina and the choroid. It is often called choroiditis or chorioretinitis. There are many infectious and non-infectious causes of posterior uveitis.
10 What is Pan-Uveitis? Pan-uveitis is a term used when all three major parts of the eye are affected by inflammation. Behcet s disease is one of the most well-known forms of pan-uveitis and it greatly damages the retina.
11 Symptoms of Uveitis: Uveitis can affect one or both eyes. Symptoms may develop rapidly and can include: Blurred vision Dark, floating spots in the vision (floaters) Eye pain Redness of the eye Sensitivity to light (photophobia) OR- A QUIET WHITE EYE
12 Juvenile Idiopathic Arthritis: It is easy to miss flare-ups due to the white and quiet presentation of this type of uveitis. Children often do not complain of visual problems, precluding the possibility of early detection. Chronic uveitis characteristically is asymptomatic in children with JIA, but leads to complications including possible blindness % of patients with JIA-associated uveitis experience severe loss of vision.
13 How Does Uveitis Occur? The cause of uveitis and arthritis in JIA remains unknown. The target antigen is unidentified. Associated factors may include the possibility of: a infectious triggers, genetic predisposition, an autoimmune response, psychological stress, and hormone interaction
14 Complications from Lack of Treatment: Cataracts (40-80%) Band keratopathy (30-80%) Macular edema in chronic cases Vitreous debris (20-30%) Glaucoma (10-30%) Chronic hypotony and phthisis (5-20%)
15 Differential Diagnosis: Ankylosing Spondylitis Dermatologic Aspects of Behcet Disease Dermatologic Manifestations of Kawasaki Disease Fuchs Heterochromic Uveitis Herpes Simplex in Emergency Medicine Herpes Zoster Inflammatory Bowel Disease Interstitial Keratitis Juvenile Xanthogranuloma Lyme Disease Pediatric Tuberculosis Psoriasis Reactive Arthritis Retinoblastoma Imaging Uveitic Glaucoma Uveitis, Anterior, Childhood Uveitis, Anterior, Nongranulomatous Vogt-Koyanagi-Harada (VKH)Disease
16 Review of Systems- Important General - Weight loss, fatigue, fever Skin - Rash, nodules, changes in nails Neck - Lymphadenopathy Respiratory - Cough, wheezing Cardiac - Chest pain/discomfort, dyspnea Gastrointestinal - Hepatomegaly, diarrhea, frequent bowel movements Genitourinary - Delayed secondary sexual characteristics, rash Musculoskeletal - Muscle or joint pain, arthritis, back pain, limitation of motion
17 Management of Uveitis: Step ladder approach: Begin with topical corticosteroids. Most patients would respond to this initial treatment. Severe disease, or chronic inflammation increases the risk for Macular Edema. These patients may be given additional nonsteroidal anti-inflammatory drugs (NSAIDs). Bilateral Uveitis may need systemic corticosteroids.
18 Side Effects of Steroids: Long-term steroid use may produce side effects such as stomach ulcers, osteoporosis (bone thinning), diabetes, cataracts, glaucoma, cardiovascular disease, weight gain, fluid retention. Usually other agents are started if it appears that patients need steroids for >3 months. Systemic immunomodulatory agents may be useful for patients with limited or no response to systemic corticosteroids or for those who develop unacceptable side effects.
19 Follow up Recommendations: Patients with JIA-associated uveitis need to be seen by an ophthalmologist regularly, every 3 or 4 months. Need an initial screening examination upon diagnosis of JIA, and the exam be performed within one month after diagnosis of JIA. After the initial screening examination, regular follow-up screenings be maintained based on risk category and classification. Screening every 6-12 months in ANA positive patients with disease onset >6 years of age who have not had uveitis within the first two years of JIA diagnosis. Patient is <6 years of age and the provider has a strong suspicion of JIA, should have a screening for uveitis.
20 Complications: If left untreated, uveitis may lead to: Glaucoma (increased pressure in the eye); Cataract (clouding of the eye's natural lens); Neovascularization (growth of new, abnormal blood vessels) Damage to the retina, including retinal detachment, damage to the optic nerve or both. These complications may need treatment with eye drops, conventional surgery or laser surgery.
21 Recommendations: It is recommended that screenings for uveitis be performed by an ophthalmologist experienced in pediatric care. Important to have good communication between the Ophthalmologist and the Rheumatologist.
22 Uveitis Associated with JIA Uveitis is the most common extra-articular complication of JIA Occurs in 11-30% of children with JIA 16% 12% 4% chronic anterior uveitis 68% acute anterior uveitis recurrent anterior uveitis panuveitis
23 Acute Anterior Uveitis in JIA Subtypes Acute anterior uveitis is often associated with eye pain, redness, headache or photophobia Most common in HLA B27-positive JIA subsets such as ankylosing spondylitis or arthritis associated with inflammatory bowel disease Often treatable with topical steroids alone
24 Chronic Anterior Uveitis JIA is the most common systemic cause of chronic anterior uveitis Chronic anterior uveitis develops in: 10-30% of pauciarticular JIA (20-40% of ANA positive pts) <10% of polyarticular JIA Most commonly seen in young ANA positive girls >65% cases are asymptomatic & bilateral, but can be unilateral
25 Chronic Anterior Uveitis in JIA Chronic anterior uveitis is usually asymptomatic at onset Failure to screen & recognize chronic anterior uveitis may lead to serious complications such as vision loss Visual acuity is best measure of disease activity & damage Screening is best done by an ophthalmologist, not an optometrist Frequency of screening by current guidelines is based on subtype of JIA & ANA status
26 Increased Risk for Chronic Anterior Uveitis in Pauciarticular JIA Young age at onset of JIA (<3 yr) ANA positivity (especially higher titers?) but alone cannot predict risk of uveitis HLA DRB1*11 haplotype (tissue typing) Female ESR >50 at time of JIA diagnosis
27 Which Occurs First? Mean time between diagnosis of JIA & uveitis onset is 1.8 yr Time between diagnoses of JIA & anterior uveitis (AU): 65% 0% 5% 30% AU before JIA AU & JIA simultaneously AU after JIA
28 Timing of Chronic Anterior Uveitis in JIA 75% patients develop chronic uveitis within 1 year after JIA diagnosis 90% by 4 years after diagnosis of JIA 50% overall develop complications in part related to topical steroids: synechiae band keratopathy cystoid macular edema vitritis glaucoma Complications related to severity of uveitis
29 Definition of Severe versus Mild Chronic Anterior Uveitis Mild: single or recurrent episodes without development of complications or need for systemic immunosuppression (as defined by treating ophthalmologist) Severe: Persistent or >2 episodes in 1 year with either: Development of complications Need for systemic immunosuppression
30 Typical Complications: Pupil Irregularity from Synechiae
31 Band Keratopathy
32 Posterior Synechiae, Cataract and Glaucoma
33 Risk Factors for Ocular Complications in Chronic Anterior Uveitis Male Young age at uveitis onset (<3 yr) Short time duration (<5 months) between development of JIA & uveitis - main risk predictor Presence of synechiae at initial diagnosis of uveitis
34 Vision Loss in JIA associated Chronic Anterior Uveitis Reduced visual acuity to 20/50: in 13-26% pts To 20/200: in 5-9% pts Risk may be decreasing due to use of methotrexate for JIA? TNF inhibitors?
35 Risk Factors for Vision Loss Increased risk with: Bilateral uveitis Long duration of eye disease (>5 yr) Presence of synechiae, band keratopathy Abnormal intraocular pressure (high or low) Persistent >1+ cells & vitreous haze History of intraocular surgery
36 JIA Uveitis is a Systemic Autoimmune Disease Uveitis is a systemic autoimmune disease not localized to eye and is treated as such Specific autoantibodies & autoreactive T cells not yet defined ANA does not appear to play role in development of uveitis Pro-inflammatory cytokines especially TNFa have pivotal role in pathogenesis of uveitis & JIA IFNg TNFa IL-1 IL-6 IL-18, etc IL-4 IL-10 TGFb IL-1RA, etc
37 Autoimmunity T&B cell-mediated responses against self eye proteins culminating in uveitis Maybe triggered by environmental factors in genetically susceptible individuals Breakdown of tolerance to SELF is key Involves loss of regulatory T cells, increased autoreactive T & B cells, imbalance between pro-inflammatory & anti-inflammatory cytokines Immune system mistakenly attacks self, damaging healthy cells and organs, causing disease
38 JIA Uveitis Treatment Topical steroids are often used 1 st, alone or with additional immunomodulation: Frequent or long tem steroid eye drops is associated with increased risks of cataracts & glaucoma Systemic steroids may be needed if uveitis is severe & rapid immunosuppression is needed Start DMARD steroid-sparing agent if uveitis not controlled with steroids or develop complications: Methotrexate (MTX) preferred Mycophenolate Cyclosporine Tacrolimus
39 Methotrexate MTX (SQ or PO) is mainstay of uveitis treatment However, 15-50% pts will have refractory uveitis despite MTX: 30% never controlled 12-20% relapse within 5 years ON MTX Relapses on MTX may be reduced if: Continue MTX for >3 years Withdraw MTX only after >2 years of inactive uveitis
40 Our New Therapies: Biologic Response Modifiers MTX-resistant pts need biologic therapy Biologics are recombinant drugs that specifically target: inflammatory cytokines co-stimulatory & adhesion molecules cell populations involved in disease pathogenesis
41 Cytokine Targets are Protein Messengers that Convey Information Between Cells via Specific Cell-surface Receptors Cell 1 Cell 2 signaling molecules Gene expression Cytokine Response
42 Cytokines in Pathogenesis of Uveitis \ IL-6, etc \ \ \ \ TNFa blood-eye barrier \ \ \ \ \ \ TNFa & other pro-inflammatory cytokines penetrate blood-eye barrier along with activated T cells causing inflammation in the eye
43 Benefits of Cytokine Inhibitors Most JIA-associated uveitis patients who fail to respond to MTX respond to a biologic Long-acting TNFa inhibitors are used first: Adalimumab Infliximab Etanercept is not recommended since short-acting TNFa inhibition has not proven efficacious in control of chronic uveitis
44 Other Biologics in Chronic Uveitis IL-6 inhibitor: Tocilizumab: Maybe helpful in patients who fail MTX & TNF inhibitors Short & long acting IL-1 inhibitors: Anakinra: Not known to be helpful Rilonacept: Not known to be helpful Canakinumab: Not known to be helpful
45 Non-Cytokine Biologics in Chronic Uveitis B-cell inhibition: Rituximab: Maybe helpful in patients who fail MTX & TNF inhibitors T-cell inhibition: Abatacept: Maybe helpful in patients who fail MTX & TNF inhibitors
46 How to Taper Biologics? No right way to wean off biologic Wean cautiously & slowly Need eye screens just before biologic is due (if infusion) in order to determine if spacing out infusions is possible close communication between rheumatologist & ophthalmologist is critical
Uveitis. Pt Info Brochure. Q: What is Uvea?
Pt Info Brochure Uveitis Q: What is Uvea? A: Uvea is the middle layer of the eye. It is the most vascular structure of the eye. It provides nutrition to the other parts of the eye. The uvea is made up
More informationApproach to Pediatric Uveitis. Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Service
Approach to Pediatric Uveitis Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Service Epidemiology Uveitis is the 3 rd leading cause of blindness in USA 5-10% of uveitis cases involve children
More informationUveitis. What is Uveitis?
Uveitis What is Uveitis? Uveitis [u-vee-i-tis] is a term for inflammation of the eye. It can occur in one eye or both eyes and affects the layer of the eye called the uvea [u-vee-uh]. It also can be associated
More informationUNDERSTAND MORE ABOUT UVEITIS UVEITIS
UNDERSTAND MORE ABOUT UVEITIS UVEITIS Uveitis What is uveitis? Uveitis is inflammation of the uvea, the middle layer of your eye. The eye is shaped much like a tennis ball, with three different layers
More informationHead prof. MUDr. E. Vlková, CSc.
MUDr. Karkanová Michala, Oční klinika LF MU a FN Brno Head prof. MUDr. E. Vlková, CSc. 3 parts: iris (iris) ciliary body (corpus ciliare) choroid (choroidea) Function: regulating the entry of light into
More informationMoncef Khairallah, MD
Moncef Khairallah, MD Department of Ophthalmology, Fattouma Bourguiba University Hospital Faculty of Medicine, University of Monastir Monastir, Tunisia INTRODUCTION IU: anatomic form of uveitis involving
More informationRegional vs. Systemic Therapy. Corticosteroids. Regional vs. Systemic Therapy for Uveitis. Considerations
Regional vs. Systemic Therapy for Uveitis Nisha Acharya,, M.D., M.S. Director, Uveitis Service F.I. Proctor Foundation University of California, San Francisco December 4, 2010 No financial disclosures
More informationManagement of uveitis
Management of uveitis DR. ANUPAMA KARANTH Anti-inflammatory agents -itis = inflammation Treatment : stop inflammation Use anti-inflammatory drugs Most potent of such agents : Corticosteroids Corticosteroids
More informationAnthony DeWilde, O.D Linwood Blvd. Kansas City, MO x
Anthony DeWilde, O.D. 4801 Linwood Blvd. Kansas City, MO 64128 816-861-4700 x 57411 anthony.dewilde@va.gov Uveitis and Glaucoma: The Seven Reasons Why IOP Can Increase in Uveitis (and What to do About
More informationScreening for Uveitis in Children
Information for patients and parents Manchester Royal Eye Hospital Paediatric Uveitis Service Screening for Uveitis in Children What is uveitis? Uveitis is inflammation of a layer of the eye, called the
More informationUVEITIS. Dr. Yılmaz ÖZYAZGAN
UVEITIS Dr. Yılmaz ÖZYAZGAN UVEITIS DEFINITION BY STRICT DEFINITION, UVEITIS IS AN INFLAMMATION OF UVEAL TRACT. BUT IN PRACTICAL, IT IS GENERALLY NOT RESTRICTED TO THE UVEA AND INVOLVES OTHER ADJACENT
More informationUVEITIS IN GENERAL. Information for patients UVEITIS CLINIC WHAT IS UVEITIS? MAIN CATEGORIES OF UVEITIS
Information for patients UVEITIS CLINIC UVEITIS IN GENERAL WHAT IS UVEITIS? The uvea is a name given to the pigmented layer of tissue inside the eye. When all or part of the uvea becomes inflamed, the
More informationA Tailored Approach to Uveitis and Associated Systemic Conditions Anthony DeWilde O.D.
A Tailored Approach to Uveitis and Associated Systemic Conditions Anthony DeWilde O.D. I. Introduction II. III. IV. A. Why I am giving this talk B. What to take from lecture Diagnosis 1. Better understanding
More informationJuvenileIdiopathicArthritis. Dr Johan Siebert
JuvenileIdiopathicArthritis Dr Johan Siebert 1 NORMAL DIARTHRODIAL JOINT Synovial is a thin membrane enclosing the joint space The joint space contains fluid that bathes the joint and reduces friction
More informationMethotrexate for uveitis associated with juvenile idiopathic arthritis: Value and requirement for additional anti-inflammatory medication
European Journal of Ophthalmology / Vol. 17 no. 5, 2007 / pp. 743-748 Methotrexate for uveitis associated with juvenile idiopathic arthritis: Value and requirement for additional anti-inflammatory medication
More informationUveitis unplugged: systemic therapy
Uveitis unplugged: systemic therapy Hobart 2017 Peter McCluskey Save Sight Institute Sydney Eye Hospital Sydney Medical School University of Sydney Sydney Australia No financial or proprietary interest
More informationUpdate on management of Anterior Uveitis
Update on management of Anterior Uveitis Parthopratim Dutta Majumder Senior Consultant, Department of Uvea & Intraocular Inflammation Medical Research Foundation, Sankara Nethralaya ABCD of Treating a
More informationThe Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis
Pediatr Drugs (2015) 17:283 301 DOI 10.1007/s40272-015-0128-2 REVIEW ARTICLE The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis Melissa A. Lerman 1 C. Egla Rabinovich 2 Published
More informationThe Leeds Teaching Hospitals NHS Trust Uveitis in children and young people
n The Leeds Teaching Hospitals NHS Trust Uveitis in children and young people A guide for young people and parents/carers This leaflet is for parents who have a child with uveitis and for young people
More informationUveitis / Iritis. Introduction. Other formats
Other formats Introduction Uveitis / Iritis If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast, British Sign Language or translated
More informationHumira. (adalimumab) Drug Update Slideshow NEW INDICATION
Humira (adalimumab) NEW INDICATION Drug Update Slideshow Introduction Brand name: Humira Generic name: Adalimumab Pharmacological class: Tumor necrosis factor (TNF) blocker Strength and Formulation: 10mg/0.2mL,
More information2/16/17. 3 main underlying causes are:
Definition Etiology Signs/Symptoms Nathan Lighthizer, O.D., F.A.A.O. Assistant Professor Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic Northeastern State University Oklahoma College
More informationWHAT IS YOUR DIAGNOSIS? By ADREA R. BENKOFF M.D.
WHAT IS YOUR DIAGNOSIS? By ADREA R. BENKOFF M.D. Anterior Chamber Inflammation and Iris Depigmentation Noted 25 Years After Cataract Extraction Decreasing Vision Over a 5- Year Period 64 year old white
More informationUveitis literature 2014: the year in review. Russell N. Van Gelder, MD, PhD Department of Ophthalmology University of Washington Seattle, WA
Uveitis literature 2014: the year in review Russell N. Van Gelder, MD, PhD Department of Ophthalmology University of Washington Seattle, WA Disclosures RVG serves as Associate Editor of IOVS Editorial
More informationNEPTUNE RED BANK BRICK
NEPTUNE RED BANK BRICK Diabetes & The Eye Diabetics are more likely to develop Cataracts at a younger age. Diabetics are twice as likely to develop Glaucoma when compared to non-diabetics. The primary
More informationGrand Rounds: Interesting and Exemplary Cases From Guanajuato and Djibouti
Learning Community: January 25, 2015 Grand Rounds: Interesting and Exemplary Cases From Guanajuato and Djibouti JORGE CUADROS, OD, PHD EyePACS In Guanajuato Program started in 2007 Cameras go from clinic
More informationOCCASIONAL COMMUNICATIONS
UVEITIS: DIAGNOSIS AND MANAGEMENT T. Akerele and S. Lightman, Department of Clinical Ophthalmology, Institute of Ophthalmology, London and Moorfields Eye Hospital, London Uveitis is a generic term which
More informationNew Drugs for Uveitis. Medical Eye Unit St Thomas Hospital
New Drugs for Uveitis Miles Stanford Medical Eye Unit St Thomas Hospital x Epithelium x x Antigen Y Y Y Y IgG m cd4 IL-2 Y m + IL-12 Cytotoxic T B pmn Ig s PG s. LTB4 O - IL-6 TNFα IFNγγ IL-2 Th1 IL-10
More information3 main underlying causes are:
Nathan Lighthizer, O.D., F.A.A.O. Assistant Professor Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic Northeastern State University Oklahoma College of Optometry Tahlequah, OK lighthiz@nsuok.edu
More informationChoroidal Neovascularization in Sympathetic Ophthalmia
Choroidal Neovascularization in Sympathetic Ophthalmia Lucia Sobrin, Miguel Cordero Coma, C. Stephen Foster Case Report A 49-year-old man presented after a ruptured globe repair of his left eye status
More informationUveitis and treatments; What's new?
Uveitis and treatments; What's new? M Usman Saeed MBBS, MRCOphth, MRCS, FRCOphth (London),FRCS ( Edinburgh) Consultant Ophthalmologist, Epsom and St Helier NHS Trust Carshalton, London www.londoneyedoctors.co.uk
More informationHLA-B27-related anterior Uveitis
HLA-B27-related anterior Uveitis Nicholas Jones Manchester Uveitis Clinic The Royal Eye Hospital Manchester Anterior means anterior only IUSG classification: Anterior uveitis = Iris & pars plicata AU
More informationWhat prescribers need to know
HUMIRA Citrate-free presentations in an Electronic Medical Record (EMR) What prescribers need to know 2 / This is your guide to identifying HUMIRA Citrate-free presentations in your Electronic Medical
More information13. Behçet s - In Children
Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk 13. Behçet s - In Children How are children affected by Behçet s disease? Behçet s disease (also
More informationJuvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA)
www.printo.it/pediatric-rheumatology/gb/intro Juvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA) Version of 2016 1. WHAT IS JUVENILE SPONDYLOARTHRITIS/ENTHESITIS- RELATED ARTHRITIS (SpA-ERA)
More informationScleritis LEN V KOH OD
Scleritis LEN V KOH OD 2014 PUCO 1 Introduction A painful, destructive, and potentially blinding disorder Highly symptomatic High association with systemic disease Immunosuppresssive agents 2014 PUCO 2
More information!! Definition. !! Etiology. !! Signs/Symptoms. !! Classification/Diagnosis. !! Systemic Associations. !! Lab Testing. !! Treatment. !!
Nathan Lighthizer, O.D., F.A.A.O. Assistant Professor Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic Northeastern State University Oklahoma College of Optometry Tahlequah, OK lighthiz@nsuok.edu!!
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationUniversity of Bristol - Explore Bristol Research
Hawkins, M. J., Dick, A. D., Lee, R. W. J., Ramanan, A. V., Carreño, E., Guly, C., & Ross, A. H. (2016). Managing juvenile idiopathic arthritisassociated uveitis. Survey of Ophthalmology, 61(2), 197-210.
More informationOphthalmology. Juliette Stenz, MD
Ophthalmology Juliette Stenz, MD Required Slide Disclosures NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT Required Slide At the end of this session, students will be able to: 1.
More informationDiagnosis of uveitis, how to proceed?
EOS meeting Cairo, 2018 Diagnosis of uveitis, how to proceed? Mohamed G.A Saleh Lecturer of Ophthalmology Assiut University Size of the problem 15/100000 in US every year. 10% of blindness Prevalence varies
More informationDr Jo-Anne Pon. Dr Sean Every. 8:30-9:25 WS #70: Eye Essentials for GPs 9:35-10:30 WS #80: Eye Essentials for GPs (Repeated)
Dr Sean Every Ophthalmologist Southern Eye Specialists Christchurch Dr Jo-Anne Pon Ophthalmologist Southern Eye Specialists, Christchurch Hospital, Christchurch 8:30-9:25 WS #70: Eye Essentials for GPs
More informationGlaucoma. Cornea. Iris
Glaucoma Introduction Glaucoma is a group of eye diseases that can lead to blindness if not treated. Openangle glaucoma, the most common form of glaucoma, affects about 3 million Americans. Half of those
More informationCoverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication
BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP
More informationBlau's Disease / Juvenile Sarcoidosis
https://www.printo.it/pediatric-rheumatology/gb/intro Blau's Disease / Juvenile Sarcoidosis Version of 2016 1. WHAT IS BLAU S DISEASE/JUVENILE SARCOIDOSIS 1.1 What is it? Blau syndrome is a genetic disease.
More informationDouble trouble: a patient with both HLA-B27 anterior uveitis and HLA-A29 birdshot chorioretinitis
Haddad and Reddy Journal of Ophthalmic Inflammation and Infection 2014, 4:28 BRIEF REPORT Open Access Double trouble: a patient with both HLA-B27 anterior uveitis and HLA-A29 birdshot chorioretinitis Zeina
More informationUveitis. What is uveitis? Types of uveitis
Uveitis Uveitis What is uveitis? Uveitis means inflammation inside the eye. It affects the part of the eye called the uvea which consists of the iris, ciliary body and choroid. Uveitis can cause serious
More informationJuvenile Idiopathic Arthritis with Associated Bilateral Anterior Uveitis in a Four Year- Old Girl
Juvenile Idiopathic Arthritis with Associated Bilateral Anterior Uveitis in a Four Year- Old Girl Pavlina S. Kemp, MD, Susannah Q. Longmuir, MD August 14, 2012 Chief complaint: Central posterior synechiae
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization MERC CARE PLA (MEDICAID) Humira (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax
More information10/18/2018. Unraveling Uveitis
Unraveling Uveitis Trenton Cleghern, OD, FAAO VisionAmerica UAB School of Optometry 11/10/2018 1 Disclosure Statement: Nothing to disclose 2 Objectives Classify uveitis Current and new therapeutic options
More informationMisdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (CSC)
HPTER 12 Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (S) linical Features VKH disease is a bilateral granulomatous panuveitis often associated with exudative
More informationCOVER FOCUS AT A GLANCE. BY LISA J. FAIA, MD, and KIMBERLY A. DRENSER, MD, PhD
PEDIATRIC UVEITIS: CHALLENGING FOR OPHTHALMOLOGISTS, PATIENTS, AND PARENTS Management of these complicated diseases differs between pediatric and adult patient populations. BY LISA J. FAIA, MD, and KIMBERLY
More informationScrub In. What is the function of vitreous humor? What does the pupil do when exposed to bright light? a. Maintain eye shape and provide color vision
Scrub In What is the function of vitreous humor? a. Maintain eye shape and provide color vision b. Maintain eye shape and refract light rays c. Provide night vision and color vision d. Provide night vision
More informationOcular Pathology. I. Congenital and/or developmental. A. Trisomy 21. Hypertelorism (widely spaced eyes) Keratoconus (cone shaped cornea)
I. Congenital and/or developmental Robbins Pathologic Basis of Disease, 6 th Ed. A. Trisomy 21 Hypertelorism (widely spaced eyes) Keratoconus (cone shaped cornea) Focal hypoplasia of iris Cataracts frequently
More informationSurgery in patients with uveitis. Lyndell Lim and Anthony Hall
Surgery in patients with uveitis Lyndell Lim and Anthony Hall Disclosures Off label treatments Paid advisory board Bayer Paid research support Allergan (makers of Ozurdex) Paid research support B and L
More informationOphthalmology Subcommittee of PTAC Meeting held 30 October (minutes for web publishing)
Ophthalmology Subcommittee of PTAC Meeting held 30 October 2014 (minutes for web publishing) Ophthalmology Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology
More informationYou can C-ME after Uveitis
You can C-ME after Uveitis Abstract: Approximately 50% of uveitis patients will present with vision loss secondary to cystoid macular edema[1]. Two patients with uveitis present with a constant decrease
More information2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.
Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis
More informationA Clinical Study of Anterior Uveitis in a Rural Hospital
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 13, Issue 3 Ver. III. (Mar. 2014), PP 55-59 A Clinical Study of Anterior Uveitis in a Rural Hospital
More informationEvolving therapies for posterior uveitis. Infliximab (Remicade) Infliximab: pharmacology. FDA-approved monoclonal antibody therapy Target
Evolving therapies for posterior uveitis Sam Dahr, M.D. September 17, 2005 Midwest Ophthalmology Conference Infliximab (Remicade) FDA approved for Crohn s disease, rheumatoid arthritis, and psoriatic arthritis
More informationAnterior Segment Disease and the Systemic Link Mile Brujic, OD, FAAO
Anterior Segment Disease and the Systemic Link Mile Brujic, OD, FAAO brujic@prodigy.net Summary As optometry s role in health care increases, so does our responsibility to appropriately diagnose and appropriately
More informationCase History. The SEVEN HABITS of Highly Effective Anterior Uveitis Management. SLEx findings: SLEx corneal findings: y.o.
The SEVEN HABITS of Highly Effective Anterior Uveitis Management Case History! 68 y.o. Caucasian female of photophobia and blurred vision! As well as a headache over right eye for 2 days! Complains Paul
More information1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.
LENGTH OF AUTHORIZATION: Initial: 3 months for Crohn s or Ulcerative Colitis; 1 year for all other indications. Renewal: 1 year dependent upon medical records supporting response to therapy and review
More informationJuvenile Idiopathic Arthritis (JIA)
Juvenile Idiopathic Arthritis (JIA) Kaveh Ardalan, MD, MS Division of Rheumatology Ann & Robert H. Lurie Children s Hospital of Chicago Assistant Professor, Pediatrics and Medical Social Sciences Northwestern
More informationClinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions. April 2018
Clinical Practice Guide for the Diagnosis, Treatment and Management of Anterior Eye Conditions This Clinical Practice Guide provides evidence-based information about current best practice in the management
More informationEtiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis
Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may
More informationReport on the Deliberation Results
Report on the Deliberation Results September 14, 216 Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau Ministry of Health, Labour and Welfare Brand Name (a) Humira
More informationCORNEAL CONDITIONS CORNEAL TRANSPLANTATION
GENERAL INFORMATION CORNEAL CONDITIONS CORNEAL TRANSPLANTATION WHAT ARE CORNEAL CONDITIONS? The cornea is the clear outer layer of the eye. Shaped like a dome, it helps to protect the eye from foreign
More informationAutoimmunity and autoinflammation
Autoimmunity and autoinflammation Primary immunodeficiencies Autoimmunity and autoinflammation 1 Primary immunodeficiencies List of some common abbreviations APECED CAPS CGD CINCA CRMO CVID FCAS FMF HIDS
More informationWhat you can expect with OZURDEX
Important Information About Noninfectious Uveitis Affecting the Back Segment of the Eye and Treatment What you can expect with OZURDEX Approved Use OZURDEX (dexamethasone intravitreal implant) is a prescription
More informationDiabetes & Your Eyes
Diabetes & Your Eyes Diabetes is a disease that occurs when the pancreas does not secrete enough insulin or the body is unable to process it properly. Insulin is the hormone that regulates the level of
More informationAnterior uveitis (iritis) FAQ s
Patient information-medical retina Anterior uveitis (iritis) FAQ s This leaflet is intended for patients who attend Moorfields Eye Hospital, who are diagnosed with an eye condition called iritis- (a very
More informationAdalimumab and dexamethasone for treating non-infectious uveitis [ID763]
Adalimumab and dexamethasone for treating non-infectious uveitis [ID763] Multiple Technology Appraisal 2 nd meeting: 12 th April 2017 Committee C Slides for Committee, projector and public [NoACIC] 1 The
More informationREFRESHER: ANTERIOR UVEITIS
REFRESHER: ANTERIOR UVEITIS 2. SAoO Kongress 28.2.2018 Messe Luzern Dr. med. Christian Böni Augenklinik Universitätsspital Zürich Christian Böni Seite 1 Anterior Uveitis: Clinical Issues Diagnostics: yes
More informationDIAGNOSIS AND MANAGEMENT OF ANTERIOR UVEITIS POA SPRING CONFERENCE BERNARD H. BLAUSTEIN, O.D., F.A.A.O.
DIAGNOSIS AND MANAGEMENT OF ANTERIOR UVEITIS POA SPRING CONFERENCE - 2009 Classification of Anterior Uveitis BERNARD H. BLAUSTEIN, O.D., F.A.A.O. A. Anatomic location 1. Iritis Cells and flare mostly in
More informationEmerging therapies for the treatment of uveitis: clinical trial observations
Review: Clinical Trial Outcomes Emerging therapies for the treatment of uveitis: clinical trial observations Clin. Invest. (2013) 3(10), 951 966 Uveitis, a leading cause of blindness in the USA and western
More informationINFORMED CONSENT FOR AVASTIN TM (BEVACIZUMAB) INTRAVITREAL INJECTION
INFORMED CONSENT FOR AVASTIN TM (BEVACIZUMAB) INTRAVITREAL INJECTION INDICATIONS: Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 years of age. It is caused by
More informationUVEITIS. Uveitis may have different causes. It can be caused by:
http://www.midwestretina.com Phone: (614)-339-8500 Toll Free: (866)-373-8462 Sugat S. Patel, M.D. Louis J. Chorich III, M.D. Dino D. Klisovic, M.D. Lisa M. Borkowski, M.D. Dominic M. Buzzacco, M.D. Johnstone
More information4. Behçet s - Treatment
Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk 4. Behçet s - Treatment Introduction Because Behçet s Syndrome/Disease is a multisystem disorder,
More informationInterim Clinical Commissioning Policy Statement: Adalimumab for Severe Refractory Uveitis. Reference: NHS England: /PS
Interim Clinical Commissioning Policy Statement: Adalimumab for Severe Refractory Uveitis Reference: NHS England: 170010/PS Publications Gateway Reference: Document Purpose Policy 05527s Document Name
More informationCases CFEH. CFEH Facebook Case #4
CFEH Cases CFEH Facebook Case #4 A 42 year old female has noticed a floater in her left eye for many years but no flashes. She also reports hazy vision in this eye that has been present all her life. She
More informationo White dot syndromes pattern recognition o Activity and damage o Quality of life o Key points o Idiopathic o Sarcoidosis o Multiple sclerosis
Introduction Clinical Assessment of Posterior Uveitis Philip I. Murray Centre for Translational Inflammation Research University of Birmingham Birmingham and Midland Eye Centre o Classification of uveitis
More informationDiabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people
Diabetic Retinopathy What is diabetic eye disease? Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. All can cause severe vision loss
More informationWhat is Enbrel? Key features
What is Enbrel? Enbrel (also known by its generic name etanercept) is a biologic medication approved in April 2004 by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe
More informationIndian Journal of Basic & Applied Medical Research; June 2013: Issue-7, Vol.-2, P
Original article Clinial Study of different types of Uveitis in Western Maharashtra *Yellambkar ST, *Chavan WM,**Tayade MC *Dept. of Ophthalmology & **Department of Physiology, Rural Medical College, Pravara
More informationUveitis Update DISCLOSURE STATEMENT. Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO
Uveitis Update Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO DISCLOSURE STATEMENT We have no direct financial or proprietary interest in any companies, products or services mentioned in this presentation.
More informationAcute Retinal Necrosis Secondary to Varicella Zoster Virus in an Immunosuppressed Post-Kidney Transplant Patient
CM&R Rapid Release. Published online ahead of print September 20, 2012 as Aperture Acute Retinal Necrosis Secondary to Varicella Zoster Virus in an Immunosuppressed Post-Kidney Transplant Patient Elizabeth
More informationThe Human Eye. Cornea Iris. Pupil. Lens. Retina
The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in
More informationUveitis of spondyloarthritis in Indian subcontinent: a cross sectional study
International Journal of Advances in Medicine Ninan F et al. Int J Adv Med. 2017 Oct;4(5):1441-1446 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20174300
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes mellitus is one of the leading causes of irreversible blindness worldwide. In the United States, it is the most common cause of blindness in people younger than 65 years.
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES HUMIRA PEDIATRIC
Generic Brand HICL GCN Exception/Other ADALIMUMAB HUMIRA 24800 HUMIRA PEDIATRIC GUIDELINES FOR USE INITIAL CRITERIA (NOTE: FOR RENEWAL CRITERIA SEE BELOW) 1. Is the patient currently taking Humira? If
More informationPrior Authorization Conditions for Approval of Humira (adalimumab) Website Form Submit request via: Fax
Prior Authorization Conditions for Approval of Humira (adalimumab) Website Form www.highmarkhealthoptions.com Submit request via: Fax - 1-855-476-4158 All requests for Humira (adalimumab) require a prior
More informationNovel anti-inflammatory compounds for ulcerative colitis and rheumatoid arthritis therapy
Novel anti-inflammatory compounds for ulcerative colitis and rheumatoid arthritis therapy JANSA, P. 1, HOLÝ, A. 1, ZÍDEK, Z. 2, JANEBA, Z. 1, KOLMAN, V. 1 1 Institute of Organic Chemistry and Biochemistry
More informationRemicade (infliximab) DRUG.00002
Applicability/Effective Date *- Florida Healthy Kids Remicade (infliximab) DRUG.00002 Override(s) Prior Authorization Step Therapy Medications Remicade (infliximab) Approval Duration 1 year Comment Intravenous
More informationINFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)
Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following: 6 years of age or older 1. Moderate to severe Crohn s disease (CD) a. Patient has fistulizing disease
More informationLECOM Health Ophthalmology
Patient Name: Date of Birth: New Patient Questionnaire Your answers will be used by your healthcare provider get an accurate history of your medical conditions and ocular concerns. If you are uncomfortable
More informationMultiple Technology Appraisal (MTA) Adalimumab, dexamethasone and sirolimus for treating non-infectious uveitis
Multiple Technology Appraisal (MTA) Adalimumab, dexamethasone and sirolimus for treating non-infectious Response to consultee and commentator comments on the draft remit and draft scope (post-referral)
More informationMMS Pharmacology Lecture 2. Antirheumatic drugs. Dr Sura Al Zoubi
MMS Pharmacology Lecture 2 Antirheumatic drugs Dr Sura Al Zoubi Revision Rheumatoid Arthritis Definition (RA): is the most common systemic inflammatory disease characterized by symmetrical inflammation
More informationPediatric Ocular Sonography
Pediatric Ocular Sonography Cicero J Torres A Silva, MD Associate Professor of Radiology 2016 SPR Pediatric Ultrasound Course Yale University School of Medicine None Disclosures Objectives of Presentation
More informationPRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique
Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with
More information